[
  {
    "ts": "2026-01-16T06:08:32+00:00",
    "headline": "Assessing Stryker (SYK) Valuation After Mixed Recent Share Price Performance",
    "summary": "Stryker stock overview after recent performance shifts Stryker (SYK) has drawn fresh attention after a mixed run, with a small gain over the past month and a slight decline across the past 3 months, prompting investors to reassess the medical technology group. See our latest analysis for Stryker. At a share price of US$362.49, Stryker has delivered a 4.1% year to date share price return, while its 1 year total shareholder return of a 4.2% decline contrasts with a 3 year total shareholder...",
    "url": "https://finance.yahoo.com/news/assessing-stryker-syk-valuation-mixed-060832121.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "913ec4df-67e0-3ebb-8580-f25cddfc1933",
      "content": {
        "id": "913ec4df-67e0-3ebb-8580-f25cddfc1933",
        "contentType": "STORY",
        "title": "Assessing Stryker (SYK) Valuation After Mixed Recent Share Price Performance",
        "description": "",
        "summary": "Stryker stock overview after recent performance shifts Stryker (SYK) has drawn fresh attention after a mixed run, with a small gain over the past month and a slight decline across the past 3 months, prompting investors to reassess the medical technology group. See our latest analysis for Stryker. At a share price of US$362.49, Stryker has delivered a 4.1% year to date share price return, while its 1 year total shareholder return of a 4.2% decline contrasts with a 3 year total shareholder...",
        "pubDate": "2026-01-16T06:08:32Z",
        "displayTime": "2026-01-16T06:08:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ff2a6f5134983064d727287d327b052",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/45SOUXdE4UXEXfW1J8nc8A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ff2a6f5134983064d727287d327b052.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZOF3ADECcYht9AxIsbHRKw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ff2a6f5134983064d727287d327b052.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-stryker-syk-valuation-mixed-060832121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-stryker-syk-valuation-mixed-060832121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T12:30:43+00:00",
    "headline": "JPM26: Medtech CEO says conference’s appeal in decline",
    "summary": "The limited time to ‘get things done’ and the high cost of attending the J.P. Morgan conference are factors that are beginning to dampen its appeal.",
    "url": "https://www.medicaldevice-network.com/news/jpm26-medtech-ceo-says-conference-appeal-in-decline/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "5788a5bb-21d2-3001-8be2-bbf2d99c4acc",
      "content": {
        "id": "5788a5bb-21d2-3001-8be2-bbf2d99c4acc",
        "contentType": "STORY",
        "title": "JPM26: Medtech CEO says conference’s appeal in decline",
        "description": "",
        "summary": "The limited time to ‘get things done’ and the high cost of attending the J.P. Morgan conference are factors that are beginning to dampen its appeal.",
        "pubDate": "2026-01-16T12:30:43Z",
        "displayTime": "2026-01-16T12:30:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/078dec82cc049003a1f28c0fb5cbd967",
          "originalWidth": 1440,
          "originalHeight": 960,
          "caption": "According to Dave Rosa",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m07wfKBZwPGeD64_Tse.JA--~B/aD05NjA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/078dec82cc049003a1f28c0fb5cbd967.cf.webp",
              "width": 1440,
              "height": 960,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u0sNvhdynbpjph0I5cc00A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/078dec82cc049003a1f28c0fb5cbd967.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/jpm26-medtech-ceo-says-conference-appeal-in-decline/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-medtech-ceo-says-conference-123043704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "SYK"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T12:13:37+00:00",
    "headline": "Is Stryker (SYK) Pricing Fully Reflect Its Mixed Recent Returns And High P/E Multiple",
    "summary": "If you are wondering whether Stryker’s share price still makes sense at current levels, the key question is how its current price lines up with the value of its underlying business. The stock last closed at US$362.49, with returns of 3.1% over the past 30 days, a 4.1% gain year to date, but a 4.2% decline over the past year. The 3 year and 5 year returns sit at 47.3% and 56.7% respectively. These mixed returns highlight how investor expectations and risk perceptions around Stryker have...",
    "url": "https://finance.yahoo.com/news/stryker-syk-pricing-fully-reflect-121337128.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1090bb1a-20be-3c79-80ec-bd4271c3e516",
      "content": {
        "id": "1090bb1a-20be-3c79-80ec-bd4271c3e516",
        "contentType": "STORY",
        "title": "Is Stryker (SYK) Pricing Fully Reflect Its Mixed Recent Returns And High P/E Multiple",
        "description": "",
        "summary": "If you are wondering whether Stryker’s share price still makes sense at current levels, the key question is how its current price lines up with the value of its underlying business. The stock last closed at US$362.49, with returns of 3.1% over the past 30 days, a 4.1% gain year to date, but a 4.2% decline over the past year. The 3 year and 5 year returns sit at 47.3% and 56.7% respectively. These mixed returns highlight how investor expectations and risk perceptions around Stryker have...",
        "pubDate": "2026-01-16T12:13:37Z",
        "displayTime": "2026-01-16T12:13:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ff2a6f5134983064d727287d327b052",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/45SOUXdE4UXEXfW1J8nc8A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ff2a6f5134983064d727287d327b052.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZOF3ADECcYht9AxIsbHRKw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ff2a6f5134983064d727287d327b052.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stryker-syk-pricing-fully-reflect-121337128.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stryker-syk-pricing-fully-reflect-121337128.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T04:36:26+00:00",
    "headline": "1 Healthcare Stock Worth Your Attention and 2 We Avoid",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 21.1% over the past six months, topping the S&P 500 by 10.6 percentage points.",
    "url": "https://finance.yahoo.com/news/1-healthcare-stock-worth-attention-043626725.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "ad987ca2-e46a-37ae-bab8-b14c7200a335",
      "content": {
        "id": "ad987ca2-e46a-37ae-bab8-b14c7200a335",
        "contentType": "STORY",
        "title": "1 Healthcare Stock Worth Your Attention and 2 We Avoid",
        "description": "",
        "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 21.1% over the past six months, topping the S&P 500 by 10.6 percentage points.",
        "pubDate": "2026-01-16T04:36:26Z",
        "displayTime": "2026-01-16T04:36:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/dce2cca4bb5848cb88bbd6212ab6060d",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "SYK Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UJ9Zt5LaUC0b.6k2CBafzw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/dce2cca4bb5848cb88bbd6212ab6060d.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/230N9.SUAZ1i1kPEB1QSXA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/dce2cca4bb5848cb88bbd6212ab6060d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/1-healthcare-stock-worth-attention-043626725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-healthcare-stock-worth-attention-043626725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "OPCH"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SYK"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]